Avinger (NASDAQ:AVGR) Trading 6.5% Higher

Avinger Inc (NASDAQ:AVGR)’s share price traded up 6.5% during mid-day trading on Friday . The stock traded as high as $1.19 and last traded at $1.14, 132,800 shares were traded during mid-day trading. A decline of 15% from the average session volume of 156,483 shares. The stock had previously closed at $1.07.

Several equities research analysts have issued reports on the company. ValuEngine downgraded Avinger from a “buy” rating to a “hold” rating in a report on Tuesday, December 3rd. Zacks Investment Research downgraded Avinger from a “buy” rating to a “hold” rating in a report on Tuesday, January 7th.

The firm has a fifty day simple moving average of $1.26 and a 200-day simple moving average of $1.44. The company has a market capitalization of $11.25 million, a P/E ratio of -0.03 and a beta of 1.68. The company has a quick ratio of 1.09, a current ratio of 1.37 and a debt-to-equity ratio of 0.50.

Avinger (NASDAQ:AVGR) last announced its quarterly earnings results on Tuesday, November 5th. The medical device company reported ($0.70) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.60) by ($0.10). The business had revenue of $2.41 million during the quarter. Avinger had a negative return on equity of 197.22% and a negative net margin of 237.51%. On average, sell-side analysts predict that Avinger Inc will post -2.14 earnings per share for the current fiscal year.

Large investors have recently bought and sold shares of the stock. Virtu Financial LLC bought a new position in shares of Avinger during the third quarter worth about $37,000. Wedbush Securities Inc. bought a new position in shares of Avinger during the third quarter worth about $63,000. Finally, Perkins Capital Management Inc. grew its holdings in shares of Avinger by 362.9% during the third quarter. Perkins Capital Management Inc. now owns 794,768 shares of the medical device company’s stock worth $660,000 after buying an additional 623,093 shares in the last quarter. Institutional investors and hedge funds own 13.57% of the company’s stock.

About Avinger (NASDAQ:AVGR)

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.

Further Reading: Correction

Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.